Current Psychiatry Reports

, Volume 9, Issue 6, pp 467–474

The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

Authors

  • Sungho Maeng
    • 10 Center DriveCRC
Article

DOI: 10.1007/s11920-007-0063-1

Cite this article as:
Maeng, S. & Zarate, C.A. Curr Psychiatry Rep (2007) 9: 467. doi:10.1007/s11920-007-0063-1

Abstract

In this article, we first review a study showing that the N-methyl-d-aspartate (NMDA) receptor antagonist ketamine leads to rapid, robust, and relatively sustained antidepressant effects in patients with treatment-resistant major depression. We then discuss our hypothesis that the therapeutic effects of monoaminergic antidepressants and ketamine may be mediated by increased AMPA-to-NMDA glutamate receptor throughput in critical neuronal circuits. We hypothesize that ketamine directly mediates this throughput, whereas monoaminergic antidepressants work indirectly and gradually; this may explain, in part, the lag of onset of several weeks to months that is observed with traditional antidepressants.

Download to read the full article text

Copyright information

© Current Medicine Group LLC 2007